Certest Diagnostics

From Immunodiagnostics to Molecular Diagnostics Solutions

We advance diagnostics through two complementary technologies, developing innovative immunodiagnostic and molecular diagnostic solutions that help laboratories deliver accurate, efficient and actionable results.

Designed for routine testing, advanced analysis and high-complexity applications, our technologies support healthcare professionals in making confident clinical decisions while responding to the evolving needs of modern diagnostics.

Two technologies. One diagnostic vision.

Immunodiagnostic
Solutions

Our IDx portfolio combines speed, automation and performance, enabling efficient workflows and dependable results from routine testing to high-throughput laboratory environments.

Rapid Test

Fast and accessible immunoassay solutions designed to support timely decision-making in laboratory and point-of-care settings.

CLIA

Automated chemiluminescence immunoassay technology delivering high sensitivity, scalability and operational efficiency for modern laboratories.

Turbilatex®

Quantitative immunoassay solutions developed for routine clinical laboratory workflows, providing reliable and reproducible results.

Molecular Diagnostic
Solutions

Our MDx portfolio supports laboratories seeking precision, flexibility and innovation through molecular testing and genomic analysis.

Viasure Real-Time PCR

Comprehensive real-time PCR solutions designed to simplify workflows while delivering accurate and reliable molecular results.

Viasure NGS

Next-generation sequencing solutions supporting advanced genomic applications, research and future-ready diagnostic strategies.

VIASURE NGS

Why Certest Diagnostics

Integrated Expertise

A complete diagnostics ecosystem combining immunodiagnostic and molecular technologies under one trusted partner.

Manufacturing Excellence

In-house development and manufacturing capabilities ensuring quality, consistency and supply reliability.

Global Reach

Supporting laboratories, distributors and healthcare organizations in more than 130 countries worldwide.

Regulatory Commitment

Strong expertise in international regulatory requirements and quality standards.

Scientific Support

Dedicated technical and scientific teams providing guidance throughout the customer journey.

Continuous Innovation

A long-term commitment to developing technologies that address the future needs of diagnostic laboratories.

Frequently Asked Questions

Immunodiagnostics (IDx) detects specific biomarkers through immunological reactions, while Molecular Diagnostics (MDx) identifies genetic material such as DNA or RNA for highly sensitive detection and analysis.

The IDx portfolio includes Rapid Test, CLIA and Turbidimetry technologies.

The MDx portfolio includes VIASURE Real-Time PCR and NGS solutions.

Certest solutions are distributed internationally through an extensive global network serving laboratories and healthcare organizations across more than 130 countries.

Yes. Our teams provide technical, scientific and regulatory support to help customers implement and maximize the value of our diagnostic solutions.

For information about distribution opportunities, please contact our team through the contact form.